Matches in Nanopublications for { ?s ?p "[In 38 cases of NSCLC (21 squamous cell carcinomas and 17 adenocarcinomas) we analyzed apoptosis by nuclear morphology and in situ DNA fragmentation end labeling and the cell kinetics by an autoradiographic method with tritiated thymidine and by immunohistochemistry with anti-proliferating cell nuclear antigen (anti-PCNA) antibodies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP221053.RAYrUk8kJJhGQfQg7P7Br8SvvWYvO5twztPWvFUaEajHQ130_assertion description "[In 38 cases of NSCLC (21 squamous cell carcinomas and 17 adenocarcinomas) we analyzed apoptosis by nuclear morphology and in situ DNA fragmentation end labeling and the cell kinetics by an autoradiographic method with tritiated thymidine and by immunohistochemistry with anti-proliferating cell nuclear antigen (anti-PCNA) antibodies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP221053.RAYrUk8kJJhGQfQg7P7Br8SvvWYvO5twztPWvFUaEajHQ130_provenance.
- NP650963.RAjGa76e_ti1cQ-L_pyCWo7vmbjGl2twyPeBg6u73Oy5o130_assertion description "[In 38 cases of NSCLC (21 squamous cell carcinomas and 17 adenocarcinomas) we analyzed apoptosis by nuclear morphology and in situ DNA fragmentation end labeling and the cell kinetics by an autoradiographic method with tritiated thymidine and by immunohistochemistry with anti-proliferating cell nuclear antigen (anti-PCNA) antibodies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP650963.RAjGa76e_ti1cQ-L_pyCWo7vmbjGl2twyPeBg6u73Oy5o130_provenance.